Cited by 173Gout, Hyperuricemia, Uric AcidBlood Pressure and Hypertension StudiesSodium Intake and Health

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Effect of Allopurinol on Blood Pressure: A Systematic Review and Meta‐Analysis

Open access

Agarwal, Vikram, Hans, Nidhi, Messerli, Franz H.·2013·The Journal of Clinical Hypertension

DOI 10.1111/j.1751-7176.2012.00701.xPMC PMC8033809

Open this paper in CoChat — free account

Abstract

J Clin Hypertens (Greenwich). 2013; 15:435–442 ©2012 Wiley Periodicals, Inc. Allopurinol is a potent xanthine oxidase inhibitor that is used in hyperuricemic patients to prevent gout. It has also been shown to decrease cardiovascular complications in a myriad of cardiovascular conditions. However, studies have reported conflicting evidence on its effects on blood pressure (BP). A systematic review was conducted using Medline, PubMed, Embase, and the Cochrane Library for all the longitudinal studies that assessed the efficacy of allopurinol on systolic and diastolic BP. A total of 10 clinical studies with 738 participants were included in the analysis. Compared with the control group, systolic BP decreased by 3.3 mm Hg (95% confidence interval [CI], 1.4–5.3 mm Hg; P=.001) and diastolic BP decreased by 1.3 mm Hg (95% CI, 0.1–2.5 mm Hg; P=.03) in patients treated with allopurinol. When analysis was restricted to the higher‐quality randomized controlled trials, similar changes in systolic and diastolic BPs were found: 3.3 mm Hg (95% CI, 0.8–5.8 mm Hg; P<.001) and 1.4 mm Hg (95% CI, 0.1–2.7 mm Hg; P=.04), respectively. Allopurinol is associated with a small but significant reduction in BP. This effect can be potentially exploited to aid in controlling BP in hypertensive patients with hyperuricemia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1751-7176.2012.00701.x

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,557
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,467
Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses
Gluud, L. L., Villumsen, J., & Gluud, C. N. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00010 · Cited by 2,266
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Culleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00003 · Cited by 1,282

Flagged first, then by citations

Show all 33 references

Sorted by citations

Items 101–172 of 172

Antihyperuricemic, Anti-Inflammatory and Antihypertensive Effect of a Dry Extract from Solidago virgaurea L. (Asteraceae)
Tămaş, M., Voștinaru, O., Soran, L., Lung, I., Opriș, O., Toiu, A., Gavan, A. D., Dinte, E., & Mogoșan, C. (2021) · Scientia Pharmaceutica · doi:10.3390/scipharm89020027 · Cited by 10
Acute effects of hypouricemia on endothelium, oxidative stress, and arterial stiffness: A randomized, double‐blind, crossover study
Becker, B. D., Hupkens, E., Dewachter, L., Coremans, C., Delporte, C., Antwerpen, P. V., Franck, T. J., Boudjeltia, K. Z., Cullus, P., & van de Borne, P. (2021) · Physiological Reports · doi:10.14814/phy2.15018 · Cited by 10
Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial
Dawson, J., Robertson, M., Dickie, D. A., Bath, P. M., Forbes, K. P. N., Quinn, T. J., Broomfield, N. M., Dani, K., Doney, A. S. F., Houston, J. G., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101863 · Cited by 10
Dissociation between Urate and Blood Pressure in Mice and in People with Early Parkinson's Disease
Chen, X., Umeh, C. C., Tainsh, R. E. T., Feng, D. D., Maguire, M., Zuo, F., Rahimian, M., Logan, R. A., Wang, X., Ascherio, A., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.039 · Cited by 10
Vascular Consequences of Hyperuricemia and Hypouricemia
Albert, D., Scudder, P. N., Bagley, P. J., & Saag, K. G. (2019) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2019.04.005 · Cited by 9
Effects of uric acid-lowering therapy in patients with essential arterial hypertension
Gruszka, K., Drożdż, T., Wojciechowska, W., Jankowski, P., Terlecki, M., Bijak, M., Hering, D., Bilo, G., Drożdż, D., & Rajzer, M. W. (2022) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000578 · Cited by 9
The reality of treatment for hyperuricemia and gout in Japan: A historical cohort study using health insurance claims data
Akari, S., Nakamura, T., Furusawa, K., Miyazaki, Y., & Kario, K. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14539 · Cited by 9
Xanthine oxidase inhibitors in ischaemic heart disease
Zdrenghea, M., Sitar-Tăut, A., Cismaru, G. L., Zdrenghea, D. T., & Pop, D. (2017) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2016-068 · Cited by 8
Crystal clear – Part II: the role of uric acid in cardiorenal disease
Borghi, C., Fogacci, F., & Cicero, A. F. G. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.106554 · Cited by 10
High serum uric acid within the normal range is a useful predictor of hypertension among Japanese community-dwelling elderly women
Kawamoto, R., Ninomiya, D., Akase, T., Kikuchi, A., & Kumagi, T. (2020) · Clinical Hypertension · doi:10.1186/s40885-020-00155-x · Cited by 7
Protease-Catalyzed Rational Synthesis of Uric Acid-Lowering Peptides in Non-aqueous Medium
Huang, X.-N., Zhang, Y., Wen, Y., Jiang, Y., & Wang, C. (2022) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-022-10367-4 · Cited by 7
Asymptomatic Hyperuricemia: Treatment Approaches According to the Risk of Cardiovascular and Renal Events
Kobalava, Z. D., & Троицкая, Е. А. (2021) · Kardiologiia · doi:10.18087/cardio.2020.12.n1158 · Cited by 7
Hyperuricemia as a Risk Factor for Cardiovascular Diseases
Hisatome, I., Li, P., Taufiq, F., Maharani, N., Kuwabara, M., Ninomiya, H., & Bahrudin, U. (2020) · Journal of Biomedicine and Translational Research · doi:10.14710/jbtr.v6i3.9383 · Cited by 13
Hyperuricemia, gout and high cardiovascular risk - how to manage them in clinical practice
Fomin, V. V., Morosova, T. E., & Цурко, В. В. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.12.000173 · Cited by 6
Allopurinol on Hypertension: Insufficient Evidence to Recommend
Gois, P. H. F., Luchi, W. M., & Seguro, A. C. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12154 · Cited by 6
Oxidative Stress in Cardiovascular Diseases: Mechanisms and Exploring Advanced Therapies
Dushyant, Balram, B., Singh, G., Kumar, N., Narwal, S., & Dhingra, A. K. (2025) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/0118715257344485250207074727 · Cited by 9
Altered gut microbial functional pathways in people with irritable bowel syndrome enable precision health insights
Patridge, E. V., Gorakshakar, A., Molusky, M. M., Ogundijo, O., Julian, C., Hu, L., Antoine, G., Vuyisich, M., Wohlman, R., & Banavar, G. S. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04205-2 · Cited by 5
Review of Hyperuricaemia and Hypertension: A Target for Treatment
Jennings, C. G. (2013) · Journal of Hypertension Open Access · doi:10.4172/2167-1095.1000164 · Cited by 5
Hyperuricemia and high blood pressure at rest and during exercise: Guilty or innocent? The jury is still out
Mulè, G., Nardi, E., Lattuca, L., & Cottone, S. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13227 · Cited by 5
Effect of Long-Term Allopurinol Therapy on Left Ventricular Mass Index in Patients with Ischemic Heart Disease; A Cross-Sectional Study
Alem, M. M., Aldosari, S., Alkahmous, A. A., Obad, A. S., Fagir, N., & Al-Ghamdi, B. S. (2019) · Vascular Health and Risk Management · doi:10.2147/vhrm.s226009 · Cited by 5
A Retrospective Cohort Study of the Effect of Gout on Mortality Among Patients with a History of Kidney Transplantation
Li, J. W., Suh, M., Brigham, M. D., Kent, J. D., LaMoreaux, B. D., Johnson, R. J., Mandell, B. F., Hadker, N., Sanchez, H. A., Francis, K. M., et al. (2020) · Annals of Transplantation · doi:10.12659/aot.920553 · Cited by 5
The nitrite reductase activity of xanthine oxidoreductase sustains cardiovascular health as mice age
Dyson, N., Khambata, R. S., Parakaw, T., Massimo, G., Khuat, N. H., Noor, A. A., Gee, L. C., Lim, I., Siddique, U., Sullivan, A. J., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103923 · Cited by 6
Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis
Liu, M., Zhao, Z., Lu, K., Luo, Q., Zhao, T., & Wang, H. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14730 · Cited by 4
Hypertension and asymptomatic hyperuricemia: algorithm of diagnostics and management (literature review)
Koziolova, N. A., & Chernyavina, A. I. (2022) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2022-28-4-316-327 · Cited by 3
Synthesis and Phosphonylation of 6-Amino-4-aryl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitriles
Nosova, N. A., Fatuev, E. D., Krylov, A. S., & Egorov, D. M. (2023) · Russian Journal of General Chemistry · doi:10.1134/s1070363223120071 · Cited by 3
Relationship Between Serum Uric Acid and Incident Hypertension in Patients with Type 2 Diabetes
Janghorbani, M., Ghanbari, H., Aminorroaya, A., & Amini, M. (2017) · The Review of Diabetic Studies · doi:10.1900/rds.2017.14.354 · Cited by 3
Metabolic risks of hyperuricemia
Николаевна, Д. Л., Красивина, И. Г., Владимирович, Д. Н., & Lugovkina, D. G. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-18-76-84 · Cited by 3
Effect of Allopurinol on Blood Pressure (Author Response to Allopurinol on Hypertension: Insufficient Evidence to Recommend)
Agarwal, V., & Messerli, F. H. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12152 · Cited by 3
Self-citation
Гіперурикемія й артеріальна гіпертензія — чи існує зв’язок?
Mishchenko, L. A. (2016) · HYPERTENSION · doi:10.22141/2224-1485.5.49.2016.83865 · Cited by 2
Is it Time to Find a Role for Uric Acid Levels in the Prevention and Management of Hypertension
Xie, J. X., & Hayek, S. S. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw139 · Cited by 2
Effects of Pharmacological Reversal of Hyperuricemia on Features of the Metabolic Syndrome in Patients with Gouty Arthritis
Marin, M., & Maalouf, N. M. (2018) · Journal of Investigative Medicine · doi:10.1136/jim-2018-000728 · Cited by 2
Reference interval and upper decission limit for serum uric acid – an evidence-based approach on Romanian population using an a posteriori method
Codreanu, C., Popoviciu, H. V., Rezuş, E., Mogoşan, C., Gardikiotis, I., & Popescu, C. C. (2019) · Revista română de medicină de laborator · doi:10.2478/rrlm-2019-0019 · Cited by 2
Gout - asymptomatic hyperuricemia with/without asymptomatic monosodium urate crystal deposition: To be treated or not?
Radak-Perović, M., & Zlatković‐Švenda, M. (2019) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh180509052r · Cited by 2
Effect of allopurinol on the treatment of chronic kidney disease: a systematic review and meta-analysis
Pezeshgi, A., Jafari, S., Pouladvand, S., Parsamanesh, N., Ghodrati, S., & Nasri, H. (2022) · Journal of Nephropharmacology · doi:10.34172/npj.2022.10566 · Cited by 1
Colchicine Prevents Cardiac Rupture in Mice with Myocardial Infarction by Inhibiting P53-Dependent Apoptosis
Shen, L., Huang, S.-D., Fan, H., & Zhai, C. (2024) · International Heart Journal · doi:10.1536/ihj.23-448 · Cited by 1
In Silico Study of Luteolin and Eriodictyol as Xanthine Oxidase Inhibitors: An Integrated Approach Using Virtual Screening, DFT, Molecular Docking, MD Simulations, and ADMET Analysis
Acharya, A., Khanal, M., Maharjan, R., Khanal, K., Gyawali, K., Kshetri, M. B., Adhikari, R., Mulmi, D. D., Lamichhane), T. R., & Lamichhane, T. R. (2026) · ChemistrySelect · doi:10.1002/slct.202504392 · Cited by 1
Introducing Allopurinol to the Medical Treatment of Marfan Syndrome: Advantages, Limitations, and Potential Extension to other Aortopathies
Egea, G., de Souza, R. B., Teixidó‐Turà, G., Mas‐Stachurska, A., Evangelista, A., & Loeys, B. (2026) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-026-07954-8 · Cited by 1
Uric acid as a cardiorenal risk factor - ready for prime-time?
Patel, K. H. K., & Goldsmith, D. J. A. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12428 · Cited by 1
Arterial hypertension and gout: the current state of the problem (literature review).
Кузьміна, А. П., & Lazarenko, O. N. (2017) · Medicni perspektivi · doi:10.26641/2307-0404.2017.4.117662 · Cited by 1
Treatment Guidelines
Roddy, E., & Doherty, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54823-6.00012-9 · Cited by 1
Uric Acid as a Biomarker in Nutritional Metabolism
Bulum, T. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-07389-2_7 · Cited by 1
Gout and Hyperuricemia—Serious Risk Factors for Morbidity and Mortality or Just Indicators of “The Good Life”—The Evidence to Date
Fernández, D., & Markenson, J. A. (2015) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-015-0016-5 · Cited by 1
GOUTY ARTHRITIS – MODERN VIEW OF THE PROBLEM
Vi, M., Петрова, М. С., Inamova, O. V., & Museichuk, M. M. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-17-106-112 · Cited by 1
Effect of febuxostat on blood pressure in hyperuricemic patients
Yao, J., Shi, X., Fan, S., Gao, Y., Hu, H., Wang, P., & Chen, Q. (2020) · Medicine · doi:10.1097/md.0000000000020673 · Cited by 1
Gut Bacteria Impact Host Uric Acid Burden and Its Association With AtherosclerosisPreprint
Kasahara, K., Kerby, R. L., Zhang, Q., Pradhan, M., Mehrabian, M., Lusis, A. J., Bergström, G. M. L., Bäckhed, F., & Rey, F. E. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.12.520169 · Cited by 1
Allopurinol improves cardiovascular phenotypes of a mouse model for Williams–Beuren syndrome reducing redox stressPreprint
Aizpuru-Gómez, A., Rodríguez-Rovira, I., Abdalla, N., Ruíz-Castro, J., Dantas, A. P., Egea, G., & Campuzano, V. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.06.668870 · Cited by 1
Allopurinol regresses left ventricular hypertrophy in patients with type 2 diabetes
Szwejkowski, B. R. (2014)
Uric Acid, Allopurinol: The Cardio-Renal Silver Bullet?
Covic, A. C., & Voroneanu, L. E. (2014) · Springer eBooks · doi:10.1007/978-3-319-09162-4_7
Reducing cardiovascular risk in chronic kidney disease : a focus on mineralocorticoid receptor antagonist and arterial stiffness in primary care
Ng, K. P. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
Gout and Heart Disease
Heslinga, M., Nurmohamed, M. T., & Gerritsen, M. (2017) · Technical report · doi:10.1016/b978-0-12-803997-7.00018-1
Uric acid, blood pressure, and gout management
Scheepers (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170707ls
Histopathological Effects of Therapeutic Doses of Combined XO-Inhibitors and ACE-Inhibitors on the Expression of VEGF-A in the Myocardium and Renal Cortex in Chronic Hypertensive Albino RatsPreprint
Rezk, H. M., & Ibrahiem, A. T. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/163824
Uric Acid-Hypertension Relationships
Berbari, A. E., Daouk, N. A., & Mancia, G. (2017) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_23
Renoprotective impact of allopurinol in elderly patients with hypertension
Mottaghi, P. (2017) · Journal of Nephropathology · doi:10.15171/jnp.20
Pengaruh Pemberian Alopurinol terhadap Tekanan Darah Pasien Gagal Jantung
Wowor, R. E., & Wantania, F. E. N. (2018) · Jurnal Biomedik JBM · doi:10.35790/jbm.10.1.2018.18997
Hypertension
Arps, K. E., & McEvoy, J. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54835-9.00003-x
5. Pathogenesis and Management of Gout and Hyperuricemia
Fujimori, S. (2018) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.107.458
The effect of allopurinol on left ventricular mass in patients with treated essential hypertension
Gingles, C. (2019) · Discovery Research Portal (University of Dundee)
Depressive Symptoms and the Effectiveness of a Urate‐Lowering Therapy in a Clinical Trial
Mrug, S., Orihuela, C. A., Rahn, E. J., Mudano, A. S., Foster, J., Saag, K. G., & Gaffo, A. (2020) · ACR Open Rheumatology · doi:10.1002/acr2.11192
尿酸・(酸性尿)と諸疾患との関連性-最近の話題-
茂子, 原. (2020) · doi:10.11320/ningendock.35.132
THE EFFECT OF OBESITY AND HIGH FAT DIET ON CARDIOVASCULAR RISK AND INTESTINAL DRUG METABOLISM
Tam, H. K. (2015) · University of Minnesota Digital Conservancy (University of Minnesota)
Uric Acid as a Biomarker in Nutritional Metabolism
Bulum, T. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81304-8_7-1
Cardiological and rheumatological expert statement on the management of asymptomatic hyperuricemia in patients at high cardiovascular risk
Barylski, M., Batko, B. P., Filipiak, K. J., Mamcarz, A., Rell‐Bakalarska, M., Samborski, W., & Wiland, P. (2022) · Rheumatology Forum · doi:10.5603/rf.2022.0007
Colchicine may be considered for the secondary prevention of cardiovascular disease
Kim, E. S., & Lee, A. (2023) · Drugs & Therapy Perspectives · doi:10.1007/s40267-023-00990-6
The Role of Uric Acid in Hypertension and Heart Failure
Borghi, C., Adorno, A., Gallelli, I., & Dall’Olio, M. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-39315-0_10
Synthesis and phosphonylation of 6-amino-4-aryl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitriles
Nosova, N. A., Fatuev, E. D., Krylov, A. S., & Egorov, D. M. (2023) · Журнал Общей Химии · doi:10.31857/s0044460x23120077
The nitrite reductase activity of xanthine oxidoreductase sustains cardiovascular healthPreprint
Dyson, N., Khambata, R. S., Parakaw, T., Massimo, G., Khuat, N. H., Noor, A. A., Gee, L. C., Lim, I., Siddique, U., Sullivan, A. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.01.621390
Association Between Serum Uric Acid and Atrial Fibrillation in Patients With Hypertension: A Systematic Review and Meta-Analysis
Tang, N., Luo, Z., Yao, Y., & Wu, G. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm28168
Phytochemical Profiling and In Silico Molecular Interactions of the Bioactivity‐Guided Fractions of Ocimum tenuiflorum L.: A Comprehensive Report of Antioxidant, Anti‐Inflammatory, and Anti‐Mutagenic Properties
Chatterjee, A., & Sarkar, B. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500349
The Relationship between Serum Uric Acid and Cardiovascular Disease and Its Underlying Molecular Mechanisms
马, 甜. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15102823
A Comprehensive Overview of the Role of Oxidative Stress and Antioxidants in Cardiovascular Diseases
Radhakrishnan, H. R. G., Chithamparam, P., & Muthukumaran, A. (2026) · Springer eBooks · doi:10.1007/978-981-96-9670-3_6
The Evolutionary Role of Urate in Humans Revisited: Relevance to Gout and Metabolic Syndrome
Nash, M. J., Razmjou, A., & FitzGerald, J. D. (2026) · Gout Urate and Crystal Deposition Disease · doi:10.3390/gucdd4030017

Authors: Agarwal, V., Hans, N., & Messerli, F. H.
Affiliations: St. Luke's-Roosevelt Hospital Center (US)
Tufts University (US)
Corresponding author: Messerli, Franz H.
ORCID: Messerli, Franz H.
Venue: The Journal of Clinical Hypertension
Publisher: Wiley
Published: 2012-08-20
Volume: 15
Issue: 6
Pages: 435-442
ISSN: 1524-6175 (ISSN-L)
1751-7176
DOI: 10.1111/j.1751-7176.2012.00701.x
PMC: PMC8033809
OpenAlex: W1516957924
Cited by: 173
References: 33
Citations by year: 2026: 4 · 2025: 8 · 2024: 9 · 2023: 14 · 2022: 17 · 2021: 8 · 2020: 15 · 2019: 17 · 2018: 20 · 2017: 15 · 2016: 17 · 2015: 10 · 2014: 11 · 2013: 8
FWCI: 1.35
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Journal of Clinical Hypertension (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Keywords: allopurinol, blood pressure, xanthine oxidase inhibitors, hyperuricemia, hypertension, systolic blood pressure, diastolic blood pressure, antihypertensive effect
MeSH terms: Allopurinol, Blood Pressure, Gout Suppressants, Humans, Hypertension

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Allopurinol on Blood Pressure: A Systematic Review and Meta‐Analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks